Australia · Delayed Price · Currency is AUD Vitura Health Statistics
Total Valuation
Vitura Health has a market cap or net worth of AUD 25.85 million. The enterprise value is 34.60 million.
| Market Cap | 25.85M |
| Enterprise Value | 34.60M |
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vitura Health has 662.74 million shares outstanding. The number of shares has increased by 13.19% in one year.
| Current Share Class | 662.74M |
| Shares Outstanding | 662.74M |
| Shares Change (YoY) | +13.19% |
| Shares Change (QoQ) | +3.10% |
| Owned by Insiders (%) | 34.70% |
| Owned by Institutions (%) | 1.28% |
| Float | 228.32M |
Valuation Ratios
The trailing PE ratio is 32.47.
| PE Ratio | 32.47 |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 4.41 |
| P/FCF Ratio | 18.72 |
| P/OCF Ratio | 17.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.64, with an EV/FCF ratio of 25.06.
| EV / Earnings | 44.13 |
| EV / Sales | 0.27 |
| EV / EBITDA | 12.64 |
| EV / EBIT | 14.55 |
| EV / FCF | 25.06 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.14 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 5.70 |
| Debt / FCF | 11.30 |
| Interest Coverage | 2.26 |
Financial Efficiency
Return on equity (ROE) is 1.15% and return on invested capital (ROIC) is 1.40%.
| Return on Equity (ROE) | 1.15% |
| Return on Assets (ROA) | 2.01% |
| Return on Invested Capital (ROIC) | 1.40% |
| Return on Capital Employed (ROCE) | 4.49% |
| Weighted Average Cost of Capital (WACC) | -2.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.75 |
| Inventory Turnover | 13.86 |
Taxes
In the past 12 months, Vitura Health has paid 1.04 million in taxes.
| Income Tax | 1.04M |
| Effective Tax Rate | 67.78% |
Stock Price Statistics
The stock price has decreased by -46.58% in the last 52 weeks. The beta is -1.78, so Vitura Health's price volatility has been lower than the market average.
| Beta (5Y) | -1.78 |
| 52-Week Price Change | -46.58% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 38.13 |
| Average Volume (20 Days) | 504,427 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitura Health had revenue of AUD 129.24 million and earned 784,131 in profits. Earnings per share was 0.00.
| Revenue | 129.24M |
| Gross Profit | 32.32M |
| Operating Income | 2.38M |
| Pretax Income | 1.54M |
| Net Income | 784,131 |
| EBITDA | 1.93M |
| EBIT | 2.38M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 6.10 million in cash and 15.61 million in debt, with a net cash position of -9.51 million or -0.01 per share.
| Cash & Cash Equivalents | 6.10M |
| Total Debt | 15.61M |
| Net Cash | -9.51M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 45.36M |
| Book Value Per Share | 0.07 |
| Working Capital | 3.24M |
Cash Flow
In the last 12 months, operating cash flow was 1.48 million and capital expenditures -96,699, giving a free cash flow of 1.38 million.
| Operating Cash Flow | 1.48M |
| Capital Expenditures | -96,699 |
| Depreciation & Amortization | -450,710 |
| Net Borrowing | -1.68M |
| Free Cash Flow | 1.38M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 25.01%, with operating and profit margins of 1.84% and 0.61%.
| Gross Margin | 25.01% |
| Operating Margin | 1.84% |
| Pretax Margin | 1.19% |
| Profit Margin | 0.61% |
| EBITDA Margin | 1.49% |
| EBIT Margin | 1.84% |
| FCF Margin | 1.07% |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 5.00%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 5.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 164.96% |
| Buyback Yield | -13.19% |
| Shareholder Yield | -8.19% |
| Earnings Yield | 3.03% |
| FCF Yield | 5.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vitura Health has an Altman Z-Score of 2.96 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.96 |
| Piotroski F-Score | 6 |